Although GLI1 is a well-established marker of glioblastoma malignancy, its expression is highly context-dependent, and the observed downregulation in females may reflect sex-specific modulation of Hedgehog signaling or differences in tumor cellular composition rather than reduced tumor aggressiveness; transcript variant–level effects were not assessed and represent an important limitation of this study. The gene discussed is GLI1; the disease is neoplasm.